CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

Standard

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. / Hybel, Trine Engelbrecht; Vase, Maja Ølholm; Lauridsen, Kristina Lystlund et al.

In: Leukemia and Lymphoma, Vol. 63, No. 6, 05.2022, p. 1479-1483.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Hybel TE, Vase MØ, Lauridsen KL, Enemark MB, Møller MB, Pedersen C et al. CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia and Lymphoma. 2022 May;63(6):1479-1483. doi: 10.1080/10428194.2021.2023741

Author

Bibtex

@article{123d636b985f4cefbbbb0458304608a2,
title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",
author = "Hybel, {Trine Engelbrecht} and Vase, {Maja {\O}lholm} and Lauridsen, {Kristina Lystlund} and Enemark, {Marie Beck} and M{\o}ller, {Michael Boe} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and {Schade Larsen}, Carsten and Francesco d{\textquoteright}Amore and Maja Ludvigsen",
note = "Funding Information: This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen{\textquoteright}s Memorial Foundation, and the Danish Lymphoma Group.",
year = "2022",
month = may,
doi = "10.1080/10428194.2021.2023741",
language = "English",
volume = "63",
pages = "1479--1483",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor & Francis ",
number = "6",

}

RIS

TY - JOUR

T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

AU - Hybel, Trine Engelbrecht

AU - Vase, Maja Ølholm

AU - Lauridsen, Kristina Lystlund

AU - Enemark, Marie Beck

AU - Møller, Michael Boe

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Hamilton-Dutoit, Stephen

AU - Obel, Niels

AU - Schade Larsen, Carsten

AU - d’Amore, Francesco

AU - Ludvigsen, Maja

N1 - Funding Information: This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen’s Memorial Foundation, and the Danish Lymphoma Group.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85122825283&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.2023741

DO - 10.1080/10428194.2021.2023741

M3 - Comment/debate/letter to the editor

C2 - 35019824

AN - SCOPUS:85122825283

VL - 63

SP - 1479

EP - 1483

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 6

ER -